These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22684556)
1. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry. Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850 [TBL] [Abstract][Full Text] [Related]
3. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry]. Wu S; Cheng Z; Yu L; Song W; Tao Y Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691 [TBL] [Abstract][Full Text] [Related]
4. Expression of maspin in non-small-cell lung cancer: correlation with clinical features. Takanami I; Abiko T; Koizumi S Clin Lung Cancer; 2008 Nov; 9(6):361-6. PubMed ID: 19073519 [TBL] [Abstract][Full Text] [Related]
5. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry. Ci H; Xu Z; Xu J; Wang Y; Wu S Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593 [TBL] [Abstract][Full Text] [Related]
6. Maspin expression and its clinical significance in non-small cell lung cancer. Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165 [TBL] [Abstract][Full Text] [Related]
7. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters. Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288 [TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays. Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036 [TBL] [Abstract][Full Text] [Related]
9. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density]. Han ZG; Yu TT; Shan L Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995 [TBL] [Abstract][Full Text] [Related]
11. Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer. Fan C; Yu J; Liu Y; Xu H; Wang E Pathol Oncol Res; 2012 Jul; 18(3):549-56. PubMed ID: 20853080 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229 [TBL] [Abstract][Full Text] [Related]
13. Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer. Yang W; Zhang Y; Fu Z; Sun X; Mu D; Yu J Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1289-96. PubMed ID: 22581165 [TBL] [Abstract][Full Text] [Related]
14. The roles of MASPIN expression and subcellular localization in non-small cell lung cancer. Wang XF; Liang B; Zeng DX; Lei W; Chen C; Chen YB; Huang JA; Gu N; Zhu YH Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391558 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
16. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer. Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248 [TBL] [Abstract][Full Text] [Related]
17. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745 [TBL] [Abstract][Full Text] [Related]
18. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241 [TBL] [Abstract][Full Text] [Related]
19. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537 [TBL] [Abstract][Full Text] [Related]
20. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry. Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]